Chong Kun Dang Holdings Corp.

₩35,900As of Sun 8 Nov 2026, 12:00 UTC
KRX:001630Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (4.03%)
Div yield 3.90%
ROE 7.86%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.48
PE TTM 3.284
TSR TTM (18.28%)
Mkt cap ₩170.9B
ROIC 3.21%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩39,431
9.83%
(48.05%)
Sell 0|9|5|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
607.59
645.57
695.46
751.34
10.21%
19.39%
18.88%
24.15%
Revenue₩B
11.59
12.05
12.34
12.18
13.19%
13.83%
10.48%
8.39%
Peers (US$126.0M)
Cap (US$)
PE
121.4M
—
126.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.571
0.537
0.413
EBIT/Intx
1.247
0.897
0.705
Own earn%
15.20
(3.79)
2.11
Sh yield%
27.34
20.40
20.71
Owners
Insiders/Inst%
3.83
43.87
Short interest%
1.46
SBC / revenue%
5.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
15–22
$1 testx
−0.1
Incr. ROIC%
5